Kangyuan Pharmaceutical announced that it achieved revenue of 0.331 billion yuan in the first three quarters, a decrease of 2.88% year-on-year; the net income attributable to shareholders of the listed company was 39.6831 million yuan, a decrease of 40.38% year-on-year.
- Latest
- Detail
3连板科源制药：前三季度净利润同比下降40.38%
Sanlian Plateau Source Pharmaceutical: Net income in the first three quarters decreased by 40.38% year-on-year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Latest
18:43
Peskov: Armenia cannot be a member of both the EU and the Eurasian Economic Union.
18:41
The first airport autonomous driving commercial project in Europe, the WeRide minibus has entered Zurich Airport in Swiss Franc.
WRD-5.37%
18:39
Alibaba: On January 8, approximately $39.985 million was spent to repurchase 3.8352 million shares.
BABA-0.94%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.